Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells

被引：0
|
作者：
Shizuko Sei
Jodie K Mussio
Quan-en Yang
Kunio Nagashima
Ralph E Parchment
Matthew C Coffey
Robert H Shoemaker
Joseph E Tomaszewski
机构：
[1] SAIC-Frederick,Laboratory of Human Toxicology and Pharmacology
[2] Inc,Electron Microscope Laboratory
[3] NCI-Frederick,Developmental Therapeutics Program
[4] SAIC-Frederick,Division of Cancer Treatment and Diagnostics
[5] Inc,undefined
[6] NCI-Frederick,undefined
[7] Oncolytics Biotech Inc,undefined
[8] National Cancer Institute,undefined
[9] National Cancer Institute,undefined
来源：
Molecular Cancer | / 8卷
关键词：
Paclitaxel; Gemcitabine; NSCLC Cell; Combination Index; NSCLC Cell Line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
    Sei, Shizuko
    Mussio, Jodie K.
    Yang, Quan-en
    Nagashima, Kunio
    Parchment, Ralph E.
    Coffey, Matthew C.
    Shoemaker, Robert H.
    Tomaszewski, Joseph E.
    MOLECULAR CANCER, 2009, 8
  • [2] Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents against non-small cell lung cancer (NSCLC)
    Sei, S.
    Yang, Q.
    Mussio, J.
    Coffey, M.
    Parchment, R.
    Shoemaker, R.
    Tomaszewski, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 103 - 103
  • [3] Experience with new chemotherapeutic agents in non-small cell lung cancer
    Natale, RB
    CHEST, 1998, 113 (01) : 32S - 39S
  • [4] Overview of current and future chemotherapeutic agents in non-small cell lung cancer
    Natale, RB
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : S29 - S37
  • [5] Immunogenic properties of chemotherapeutic agents in the treatment of non-small cell lung cancer
    Flieswasser, Tal
    Van Loenhout, Jinthe
    Boullosa, Laurie Freire
    Van den Eynde, Astrid
    De Waele, Jorrit
    Van Audenaerde, Jonas
    Lardon, Filip
    Smits, Evelien
    Pauwels, Patrick
    Julie, Jacobs
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Mechanisms of antitumor activity by melanoxoin on human non-small cell lung cancer cells
    Peng, C. Y.
    Wu, S. F.
    Hung, H. Y.
    Wu, Y. C.
    PLANTA MEDICA, 2012, 78 (11) : 1098 - 1098
  • [7] Do newer chemotherapeutic agents improve survival in non-small cell lung cancer?
    Rigas, JR
    SEMINARS IN ONCOLOGY, 1998, 25 (03) : 5 - 9
  • [8] Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration
    Mamdani, Hirva
    Jalal, Shadia I.
    Hanna, Nasser
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (10)
  • [9] Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration
    Hirva Mamdani
    Shadia I. Jalal
    Nasser Hanna
    Current Treatment Options in Oncology, 2015, 16
  • [10] New chemotherapeutic agents in the treatment of non-small cell lung cancer - The Australian experience
    Boyer, MJ
    CHEST, 1998, 113 (01) : 24S - 27S
12345